title: Arsenite-induced stress signaling: modulation of the phosphoinositide 3'-kinase/Akt/FoxO signaling cascade.
abstract: FoxO transcription factors and their regulators in the phosphoinositide 3'-kinase (PI3K)/Akt signaling pathway play an important role in the control of cellular processes involved in carcinogenesis, such as proliferation and apoptosis. We have previously demonstrated that physiologically relevant heavy metal ions, such as copper or zinc ions, can stimulate this pathway, triggering phosphorylation and nuclear export of FoxO transcription factors. The present study aims at investigating the effect of arsenite on FoxO transcription factors and the role of PI3K/Akt signaling therein. Exposure of HaCaT human keratinocytes to arsenite resulted in a distinct decrease of glutathione levels only at cytotoxic concentrations. In contrast, a strong phosphorylation of FoxO1a/FoxO3a and Akt was observed at subcytotoxic concentrations of arsenite in HaCaT human keratinocytes. A time- and concentration-dependent increase in phosphorylation of FoxO1a and FoxO3a at sites known to be phosphorylated by Akt as well as phosphorylation of Akt at Ser-473 was detected. These phosphorylations were blunted in the presence of wortmannin, pointing to the involvement of PI3K.
authors.affiliation: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
authors.forename: Ingrit
authors.initials: I
authors.lastname: Hamann
authors.forename: Lars-Oliver
authors.initials: LO
authors.lastname: Klotz
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D018053:Arsenites / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D002460:Cell Line; D003300:Copper / Q000494:pharmacology; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D010766:Phosphorylation; D000077191:Wortmannin
chemical_list: D000730:Androstadienes; D018053:Arsenites; D051858:Forkhead Transcription Factors; D003300:Copper; D005978:Glutathione; C015001:arsenite; D000077191:Wortmannin
keywords: Akt; Arsenic; Copper; FoxO transcription factors; HaCaT cells
references.citation: J Cell Biol. 1988 Mar;106(3):761-71
references.pmid: 2450098
references.citation: Annu Rev Pharmacol Toxicol. 2007;47:243-62
references.pmid: 17002598
references.citation: J Biochem Mol Toxicol. 2006;20(1):48-56
references.pmid: 16498640
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2004;84:1-477
references.pmid: 15645577
references.citation: Horm Metab Res. 2011 Apr;43(4):268-74
references.pmid: 21332026
references.citation: Biochem Biophys Res Commun. 2008 Jan 11;365(2):316-21
references.pmid: 17986386
references.citation: Arch Biochem Biophys. 2002 Jan 15;397(2):232-9
references.pmid: 11795876
references.citation: Mol Med. 2001 Nov;7(11):767-72
references.pmid: 11788791
references.citation: Curr Drug Targets. 2011 Aug;12(9):1322-50
references.pmid: 21443460
references.citation: Science. 2005 May 20;308(5725):1181-4
references.pmid: 15905404
references.citation: Toxicol Appl Pharmacol. 2012 Sep 15;263(3):273-80
references.pmid: 22771847
references.citation: Toxicology. 2011 May 10;283(2-3):65-87
references.pmid: 21414382
references.citation: Toxicol Appl Pharmacol. 2005 Aug 1;206(1):66-72
references.pmid: 15963345
references.citation: Methods Enzymol. 1985;113:548-55
references.pmid: 4088074
references.citation: Cancer Biol Ther. 2011 Aug 15;12(4):253-9
references.pmid: 21613825
references.citation: Free Radic Biol Med. 2011 Jul 15;51(2):257-81
references.pmid: 21554949
references.citation: Carcinogenesis. 2003 May;24(5):967-74
references.pmid: 12771042
references.citation: Arch Biochem Biophys. 2002 Aug 15;404(2):271-8
references.pmid: 12147265
references.citation: J Biochem. 2011 Oct;150(4):345-56
references.pmid: 21856739
references.citation: Oncogene. 2005 Nov 14;24(50):7410-25
references.pmid: 16288288
references.citation: Trends Endocrinol Metab. 2005 May-Jun;16(4):183-9
references.pmid: 15860415
references.citation: J Inorg Biochem. 2012 Mar;108:141-9
references.pmid: 22197475
references.citation: Nature. 2002 Sep 19;419(6904):316-21
references.pmid: 12239572
references.citation: Arch Biochem Biophys. 2010 Sep 1;501(1):58-64
references.pmid: 20513639
references.citation: Toxicol Sci. 2011 Oct;123(2):305-32
references.pmid: 21750349
references.citation: Arch Biochem Biophys. 2007 Jul 15;463(2):175-82
references.pmid: 17509519
references.citation: Mutat Res. 2012 Jul 1;735(1-2):32-8
references.pmid: 22564430
references.citation: Biometals. 2009 Apr;22(2):307-16
references.pmid: 18925359
references.citation: Toxicol Appl Pharmacol. 2004 Aug 1;198(3):394-404
references.pmid: 15276419
references.citation: Science. 2002 Mar 29;295(5564):2450-2
references.pmid: 11884717
references.citation: Arch Toxicol. 2013 Jun;87(6):969-79
references.pmid: 22811022
references.citation: Arch Biochem Biophys. 2006 Oct 15;454(2):107-13
references.pmid: 16973122
references.citation: J Biol Chem. 2003 Oct 3;278(40):38360-7
references.pmid: 12874275
references.citation: Arch Toxicol. 2008 Aug;82(8):493-512
references.pmid: 18496671
references.citation: Hepatology. 2008 Dec;48(6):1998-2006
references.pmid: 18972406
references.citation: Antioxid Redox Signal. 2009 May;11(5):1015-27
references.pmid: 19132878
references.citation: J Biol Chem. 2011 Jan 28;286(4):2843-52
references.pmid: 21097842